Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-15-000878
Filing Date
2015-03-02
Accepted
2015-03-02 16:36:10
Documents
13
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ptx_10k.htm 10-K 3262066
2 LIST OF SUBSIDIARIES ex_211.htm EX-21.1 15226
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_231.htm EX-23.1 3469
4 CERTIFICATION ex_311.htm EX-31.1 13374
5 CERTIFICATION ex_312.htm EX-31.2 16563
6 CERTIFICATION ex_321.htm EX-32.1 11226
7 img01.jpg GRAPHIC 50750
  Complete submission text file 0001354488-15-000878.txt   13801422

Data Files

Seq Description Document Type Size
8 ptx-20141231.xml EX-101.INS 2021614
9 ptx-20141231.xsd EX-101.SCH 86718
10 ptx-20141231_cal.xml EX-101.CAL 85936
11 ptx-20141231_def.xml EX-101.DEF 205831
12 ptx-20141231_lab.xml EX-101.LAB 607700
13 ptx-20141231_pre.xml EX-101.PRE 433621
Mailing Address 884 JOHNNIE DODDS BLVD SUITE 201 MOUNT PLEASANT SC 29464
Business Address 884 JOHNNIE DODDS BLVD SUITE 201 MOUNT PLEASANT SC 29464 (832) 934-1825
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14494 | Film No.: 15665160
SIC: 2834 Pharmaceutical Preparations